Sora Ely, MD, emphasized that national lung cancer screening rates remain below 10%, underscoring the urgent need for greater ...
Mayo Clinic researchers and collaborators have identified a previously unrecognized way lung tumors weaken the immune system, ...
Eli Lilly and Co. (NYSE:LLY) on Monday shared positive topline results from the Phase 3 LIBRETTO-432 clinical trial for ...
To address the awareness gap, the American Lung Association launched a website called “Saved by the Scan,” where anyone can take a quiz to see if they should get screened.
SurvivorNet on MSN
Could timing give your cancer treatment a boost? New study on the best time to receive immunotherapy & chemo for non-small cell lung cancer
A new randomized clinical trial showed that receiving immunochemotherapy infusions earlier in the day may help patients with ...
Researchers recently tried an experiment: Gather people who had the same kind of lung cancer and put them on the same type of treatments to fire up their immune systems. The only difference was that ...
Patients with stage 4 lung cancer and EGFR mutations may benefit from combination therapies that improve disease control. The American Society of Clinical Oncology (ASCO) released updated treatment ...
Discover how precision lung cancer care tackles gene fusions, new HER2/ROS1/ALK drugs, expanded screening, and liquid ...
The FDA has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and only subcutaneous, chemo-free ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results